113 related articles for article (PubMed ID: 38030164)
1. Potential Roles of Activin in Head and Neck Squamous Cell Carcinoma Progression and Mortality.
Buryska S; Patel K; Wuertz B; Gaffney PM; Ondrey F
Anticancer Res; 2023 Dec; 43(12):5299-5310. PubMed ID: 38030164
[TBL] [Abstract][Full Text] [Related]
2. Expression and gene regulation network of INHBA in Head and neck squamous cell carcinoma based on data mining.
Wu ZH; Tang Y; Niu X; Cheng Q
Sci Rep; 2019 Oct; 9(1):14341. PubMed ID: 31586103
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of RUNX2/Activin-A Axis upon miR-376c Downregulation Promotes Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma.
Chang WM; Lin YF; Su CY; Peng HY; Chang YC; Lai TC; Wu GH; Hsu YM; Chi LH; Hsiao JR; Chen CL; Chang JY; Shieh YS; Hsiao M; Shiah SG
Cancer Res; 2016 Dec; 76(24):7140-7150. PubMed ID: 27760788
[TBL] [Abstract][Full Text] [Related]
4. UBE2C promotes the progression of head and neck squamous cell carcinoma.
Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
[TBL] [Abstract][Full Text] [Related]
6. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis.
Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS
Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
Qi CL; Sheng JF; Huang ML; Zou Y; Wang YP; Wang F; Zeng F; Hua QQ; Chen SM
Medicine (Baltimore); 2021 Feb; 100(6):e24618. PubMed ID: 33578572
[TBL] [Abstract][Full Text] [Related]
8. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
9. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
10. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
[TBL] [Abstract][Full Text] [Related]
11. Long non‑coding RNA MIR4435‑2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR‑383‑5p/RBM3 axis.
Wang S; Chen X; Qiao T
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846802
[TBL] [Abstract][Full Text] [Related]
12. High eukaryotic initiation factor 5A2 expression predicts poor prognosis and may participate in the SNHG16/miR-10b-5p/EIF5A2 regulatory axis in head and neck squamous cell carcinoma.
Ye S; Wang D; Jin M; Du J; Chen X; Zhang H; Zhou C; Fang S; Liu K
J Clin Lab Anal; 2023 Jan; 37(1):e24820. PubMed ID: 36550070
[TBL] [Abstract][Full Text] [Related]
13. MMP1 Overexpression Promotes Cancer Progression and Associates with Poor Outcome in Head and Neck Carcinoma.
Zhang W; Huang X; Huang R; Zhu H; Ye P; Lin X; Zhang S; Wu M; Jiang F
Comput Math Methods Med; 2022; 2022():3058342. PubMed ID: 36105241
[TBL] [Abstract][Full Text] [Related]
14. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
[TBL] [Abstract][Full Text] [Related]
15. CD44(+) tumor cells promote early angiogenesis in head and neck squamous cell carcinoma.
Ludwig N; Szczepanski MJ; Gluszko A; Szafarowski T; Azambuja JH; Dolg L; Gellrich NC; Kampmann A; Whiteside TL; Zimmerer RM
Cancer Lett; 2019 Dec; 467():85-95. PubMed ID: 31593802
[TBL] [Abstract][Full Text] [Related]
16. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma.
Zhou C; Li J; Li Q; Liu H; Ye D; Wu Z; Shen Z; Deng H
J Clin Lab Anal; 2019 Jun; 33(5):e22873. PubMed ID: 30843252
[TBL] [Abstract][Full Text] [Related]
18. CEACAM5 inhibits the lymphatic metastasis of head and neck squamous cell carcinoma by regulating epithelial-mesenchymal transition via inhibiting MDM2.
Wang X; Li Y; Pan M; Lu T; Wang M; Wang Z; Liu C; Hu G
Clin Sci (Lond); 2022 Nov; 136(22):1691-1710. PubMed ID: 36377775
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of the expression of activin A in esophageal carcinoma.
Yoshinaga K; Mimori K; Yamashita K; Utsunomiya T; Inoue H; Mori M
Int J Oncol; 2003 Jan; 22(1):75-80. PubMed ID: 12469187
[TBL] [Abstract][Full Text] [Related]
20. Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis.
Yang K; Zhang S; Zhang D; Tao Q; Zhang T; Liu G; Liu X; Zhao T
Int J Clin Oncol; 2019 Sep; 24(9):1030-1041. PubMed ID: 30937621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
